Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [1157]

Comment: Urothelial cancer research from ASCO GU 2018

Dr Guru Sonpavde - Dana-Farber Cancer Institute, Boston, USA

Comment: Urothelial cancer research from ASCO GU 2018 ( Dr Guru Sonpavde - Dana-Farber Cancer Institute, Boston, USA )

VinCaP: A phase II trial of vinflunine chemotherapy in locally-advanced and...

Dr Lisa Pickering - The Royal Marsden NHS Foundation Trust, London, UK

VinCaP: A phase II trial of vinflunine chemotherapy in locally-advanced and metastatic carcinoma of the penis ( Dr Lisa Pickering - The Royal Marsden NHS Foundation Trust, London, UK )

Genomic profiling of muscle invasive bladder cancer to predict response to...

Dr David Miyamoto - Massachusetts General Hospital, Boston, USA

Genomic profiling of muscle invasive bladder cancer to predict response to bladder-sparing trimodality therapy ( Dr David Miyamoto - Massachusetts General Hospital, Boston, USA )

Tumour fraction in circulating free DNA as a biomarker of disease dynamics in...

Dr Atish Choudhury - Dana-Farber Cancer Institute, Boston, USA

$Tumour fraction in circulating free DNA as a biomarker of disease dynamics in metastatic prostate cancer ( Dr Atish Choudhury - Dana-Farber Cancer Institute, Boston, USA )$

Crizotinib for advanced papillary renal cell carcinoma with MET mutations or...

Prof Patrick Schöffski - The Katholieke Universiteit Leuven, Leuven, Belgium

Crizotinib for advanced papillary renal cell carcinoma with MET mutations or amplification ( Prof Patrick Schöffski - The Katholieke Universiteit Leuven, Leuven, Belgium )

Serum miRNA to predict post-chemotherapy viable disease in testicular non...

Dr Ricardo Leão - University of Toronto, Toronto, Canada

Serum miRNA to predict post-chemotherapy viable disease in testicular non-seminomatous germ cell tumour patients ( Dr Ricardo Leão - University of Toronto, Toronto, Canada )

Radium-223 for bone predominant metastatic castration resistant prostate cancer

Dr Andrew Armstrong - Duke University School of Medicine, Durham, USA

Radium-223 for bone predominant metastatic castration resistant prostate cancer ( Dr Andrew Armstrong - Duke University School of Medicine, Durham, USA )

FALCON: Impact of 18F-fluciclovine PET/CT on management of biochemically...

Dr Eugene Teoh - University of Oxford, Oxford, UK

FALCON: Impact of 18F-fluciclovine PET/CT on management of biochemically recurrent prostate cancer ( Dr Eugene Teoh - University of Oxford, Oxford, UK )

PROSPER RCC study of perioperative nivolumab for renal cell carcinoma - future...

Dr Lauren Harshman - Dana-Farber Cancer Institute, Boston, USA

PROSPER RCC study of perioperative nivolumab for renal cell carcinoma - future trial ( Dr Lauren Harshman - Dana-Farber Cancer Institute, Boston, USA )

POUT: Phase III randomised trial of perioperative chemotherapy vs surveillance...

Dr Alison Birtle - Lancashire Teaching Hospitals NHS Foundation Trust...

POUT: Phase III randomised trial of perioperative chemotherapy vs surveillance in upper tract urothelial cancer ( Dr Alison Birtle - Lancashire Teaching Hospitals NHS Foundation Trust, Lancashire, UK )

Updates on non-metastatic castration-resistant prostate cancer

Prof Kurt Miller, Prof Silke Gillessen, Prof Heather Payne and Dr Eric Small

Updates on non-metastatic castration-resistant prostate cancer ( Prof Kurt Miller, Prof Silke Gillessen, Prof Heather Payne and Dr Eric Small )

Latest in adjuvant therapy for renal cell carcinoma

Dr Naomi Haas - University of Pennsylvania, Philadelphia, USA

Latest in adjuvant therapy for renal cell carcinoma ( Dr Naomi Haas - University of Pennsylvania, Philadelphia, USA )

More from ecancer